Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study-Reference-Cited by-同舟云学术

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

Published:2009-01 Issue:9660 Volume:373 Page:309-317
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Collet Jean-Philippe,Hulot Jean-Sébastien,Pena Anna,Villard Eric,Esteve Jean-Baptiste,Silvain Johanne,Payot Laurent,Brugier Delphine,Cayla Guillaume,Beygui Farzin,Bensimon Gilbert,Funck-Brentano Christian,Montalescot Gilles

Publisher

Elsevier BV

Subject

General Medicine

Reference43 articles.

1. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute;Smith;Circulation,2006

2. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity;Gurbel;Circulation,2003

3. Variability in individual responsiveness to clopidogrel clinical implications, management, and future perspectives;Angiolillo;J Am Coll Cardiol,2007

4. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis;Buonamici;J Am Coll Cardiol,2007

5. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement;Hochholzer;J Am Coll Cardiol,2006

Cited by 825 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach;International Journal of Cardiology;2024-11

2. Association of genetic variations of 3′-UTR in clopidogrel pharmacokinetic-relevant genes with clopidogrel response in Han Chinese patients with coronary artery disease;European Journal of Pharmaceutical Sciences;2024-09

3. Genotype-Guided Antiplatelet Therapy;Journal of the American College of Cardiology;2024-09

4. Cost-Effectiveness Analysis of Genotype-Guided Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention in Korea;Drug Targets and Therapeutics;2024-03-31

5. A Phase 1 Study of Novel Antiplatelet Agent to Overcome Pharmacogenomic Limitations of Clopidogrel;2024-03-26